Reuters logo
4 months ago
BRIEF-JCR Pharmaceuticals initiates phase 1/2 clinical trial of jr-141 in hunter syndrome
March 31, 2017 / 7:37 AM / 4 months ago

BRIEF-JCR Pharmaceuticals initiates phase 1/2 clinical trial of jr-141 in hunter syndrome

1 Min Read

March 31 (Reuters) - JCR Pharmaceuticals Co Ltd :

* Says co initiates phase 1/2 clinical trial of jr-141 in hunter syndrome

Source text in Japanese: goo.gl/axW7jJ

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below